David N. Hurst

483 total citations
18 papers, 354 citations indexed

About

David N. Hurst is a scholar working on Organic Chemistry, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David N. Hurst has authored 18 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 9 papers in Pharmacology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in David N. Hurst's work include Inflammatory mediators and NSAID effects (8 papers), Neuropeptides and Animal Physiology (6 papers) and Asymmetric Synthesis and Catalysis (4 papers). David N. Hurst is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Neuropeptides and Animal Physiology (6 papers) and Asymmetric Synthesis and Catalysis (4 papers). David N. Hurst collaborates with scholars based in United Kingdom. David N. Hurst's co-authors include Adrian Hall, Gerard M.P. Giblin, Susan H. Brown, Alan Naylor, Peter J. Machin, A. R. Chowdhury, Paul Goldsmith, Andy Billinton, Tiziana Scoccitti and Thomas G. Hayhow and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

David N. Hurst

18 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David N. Hurst United Kingdom 13 179 108 99 43 40 18 354
Stephen R. Bertenshaw United States 11 258 1.4× 150 1.4× 126 1.3× 29 0.7× 57 1.4× 14 441
Malken Bayrakdarian Canada 13 239 1.3× 47 0.4× 146 1.5× 26 0.6× 43 1.1× 17 390
Jaume Pascual Spain 9 239 1.3× 134 1.2× 110 1.1× 12 0.3× 25 0.6× 13 385
S. Kesten United States 8 187 1.0× 114 1.1× 133 1.3× 42 1.0× 11 0.3× 13 361
Norman L. Colbry United States 12 199 1.1× 56 0.5× 174 1.8× 38 0.9× 30 0.8× 19 401
Theodros Asberom United States 12 267 1.5× 90 0.8× 171 1.7× 32 0.7× 59 1.5× 19 516
R. Gericke Germany 9 340 1.9× 107 1.0× 162 1.6× 57 1.3× 25 0.6× 15 526
Fuk‐Wah Sum United States 11 271 1.5× 51 0.5× 214 2.2× 28 0.7× 20 0.5× 13 485
Fengming Chu China 11 248 1.4× 98 0.9× 151 1.5× 16 0.4× 14 0.3× 22 450
Mitsuru Oka Japan 13 146 0.8× 57 0.5× 230 2.3× 47 1.1× 68 1.7× 23 628

Countries citing papers authored by David N. Hurst

Since Specialization
Citations

This map shows the geographic impact of David N. Hurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. Hurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. Hurst more than expected).

Fields of papers citing papers by David N. Hurst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. Hurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. Hurst. The network helps show where David N. Hurst may publish in the future.

Co-authorship network of co-authors of David N. Hurst

This figure shows the co-authorship network connecting the top 25 collaborators of David N. Hurst. A scholar is included among the top collaborators of David N. Hurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. Hurst. David N. Hurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Billinton, Andy, Susan H. Brown, A. R. Chowdhury, et al.. (2011). Discovery of a novel series of nonacidic benzofuran EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(14). 4343–4348. 13 indexed citations
2.
Hall, Adrian, Andy Billinton, Susan H. Brown, et al.. (2009). Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP1 receptor antagonist for the treatment of inflammatory pain. Bioorganic & Medicinal Chemistry Letters. 19(9). 2599–2603. 15 indexed citations
3.
Hall, Adrian, Susan H. Brown, Chris Budd, et al.. (2008). Discovery of GSK345931A: An EP1 receptor antagonist with efficacy in preclinical models of inflammatory pain. Bioorganic & Medicinal Chemistry Letters. 19(2). 497–501. 23 indexed citations
4.
Hall, Adrian, Andy Billinton, Susan H. Brown, et al.. (2008). Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping. Bioorganic & Medicinal Chemistry Letters. 18(8). 2684–2690. 23 indexed citations
5.
Hall, Adrian, Rino A. Bit, Susan H. Brown, et al.. (2008). Novel methylene-linked heterocyclic EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(5). 1592–1597. 10 indexed citations
6.
Hall, Adrian, Andy Billinton, Susan H. Brown, et al.. (2008). Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy. Bioorganic & Medicinal Chemistry Letters. 18(11). 3392–3399. 66 indexed citations
7.
Hall, Adrian, Rino A. Bit, Susan H. Brown, et al.. (2006). Discovery of novel biaryl heterocyclic EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(10). 2666–2671. 16 indexed citations
8.
9.
Pickett, Stephen D., Bradley Sherborne, Trevor Wilkinson, et al.. (2003). Discovery of novel low molecular weight inhibitors of IMPDH via virtual needle screening. Bioorganic & Medicinal Chemistry Letters. 13(10). 1691–1694. 25 indexed citations
10.
Beddoes, Roy L., et al.. (1995). On the aldol reactions of β - (tri - n -butylstannyl)propionates. Tetrahedron Letters. 36(15). 2641–2644. 8 indexed citations
11.
Beddoes, Roy L., et al.. (1995). A stereospecific synthesis of 2-oxabicyclo[3.1.0]hexanes. Tetrahedron Letters. 36(3). 471–474. 15 indexed citations
12.
13.
Hurst, David N., et al.. (1986). ChemInform Abstract: β‐Adrenoceptor Activity of the Stereoisomers of the Bufuralol Alcohol and Ketone Metabolites.. Chemischer Informationsdienst. 17(9). 2 indexed citations
14.
Machin, Peter J., et al.. (1985). .beta.-Adrenoceptor activity of the stereoisomers of the bufuralol alcohol and ketone metabolites. Journal of Medicinal Chemistry. 28(11). 1648–1651. 27 indexed citations
15.
Hurst, David N., et al.. (1984). ChemInform Abstract: β1‐SELECTIVE ADRENOCEPTOR ANTAGONISTS. 3. 4‐AZOLYL LINKED PHENOXYPROPANOLAMINES. Chemischer Informationsdienst. 15(38). 1 indexed citations
16.
Machin, Peter J., et al.. (1984). .beta.1-Selective adrenoceptor antagonists. 3. 4-Azolyl linked phenoxypropanolamines. Journal of Medicinal Chemistry. 27(4). 503–509. 20 indexed citations
17.
Mungall, Dennis, et al.. (1983). Individualizing theophylline therapy: the impact of clinical pharmacokinetics on patient outcomes.. PubMed. 5(1). 95–101. 30 indexed citations
18.
Machin, Peter J., et al.. (1983). .beta.1-Selective adrenoceptor antagonists. 2. 4-Ether-linked phenoxypropanolamines. Journal of Medicinal Chemistry. 26(11). 1570–1576. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen R. Bertenshaw Breakdown of academic impact, for papers by Malken Bayrakdarian Breakdown of academic impact, for papers by Jaume Pascual Breakdown of academic impact, for papers by S. Kesten Breakdown of academic impact, for papers by Norman L. Colbry Breakdown of academic impact, for papers by Theodros Asberom Breakdown of academic impact, for papers by R. Gericke Breakdown of academic impact, for papers by Fuk‐Wah Sum Breakdown of academic impact, for papers by Fengming Chu Breakdown of academic impact, for papers by Mitsuru Oka
Rankless by CCL
2026